Deposit $100 to get a $100 trading bonus. Use the promo code AMANAWEB.
Deposit $200 to get a $100 trading bonus.
Use the promo code AMANAWEB.

+12.65%
Today
+10.40%
1D
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Name
GeneDx Holdings Corp Leveraged
Currency
USD
Standard Leverage
3X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
52 Week High
0.0012 USD
52 Week Low
0.0002 USD
Trading Hours
See hours
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx
+10.40%
WGS
+12.60%
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside
tradingview.com
4d ago

GeneDx
+10.40%
WGS
+12.60%
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $83.89, Implies 24% Upside
tradingview.com
4d ago

GeneDx
+10.40%
WGS
+12.60%
WGS: Record revenue, strong demand, and expanded coverage drive profitable growth and future upside
tradingview.com
5d ago

Show more
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.